Skip to Main Content

Paper Details

Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.
J Infect Dis
0
2023
-, CCS, CD4, CD4 TCM, CD4 TEMRA cell subsets, CD8, CD8 T cells, COVID-19, Coronavirus disease 2019, Good, IFN-, IFN-+, IFN-+ T cells, SARS, SARS-, SARS-COV-2 Cytotoxic T Lymphocytes, SARS-CoV, SARS-CoV-, SARS-CoV-2, SARS-CoV-2 virus-specific cytotoxic T-cell lymphocytes, SARS-CoV-2-vCTLs, T cells, T-cell receptor, TEM, TEM, CD4 TCM, and CD4 TEMRA cell subsets, interferon, interleukin, memory CD8 and CD4 T cells, peripheral blood mononuclear cells, severe acute respiratory syndrome coronavirus, tumor necrosis factor superfamily, vCTLs
Author NameAffiliation
Elaine R MardisThe Ohio State University
Elaine R MardisThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital
Elaine R MardisThe Ohio State University
Elaine R MardisThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital
Katherine E MillerThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital
  • 1 - 5

Datasets

Release 1.2